Patients with depression, for example, have higher levels of biomarkers that promote atherosclerosis; in anxiety and depression, we see reduced heart rate variability suggesting decreased parasympathetic activity; altered serotonergic pathways; altered platelet aggregability; and increased C-reactive protein, an indicator of increased inflammatory response. Here, CRP is linked to depressive symptom measurement.